TORTOLA, BVI / ACCESSWIRE / August 27, 2020 / Enlighta Inc. (TSXV:NLTA) ("Enlighta" or the "Company") announces that the Company was working on a transaction with a confidential private company and with an abundance of caution requested a market halt trading.
At this time, the parties will not continue to pursue the transaction and have discontinued discussions.
Enlighta will continue to pursue and evaluate other businesses and strategic opportunities and will make further announcements with respect to these efforts as soon as practically possible.
Trading of the common shares of the Corporation is expected to resume trading on TSX Venture Exchange (the "TSXV") subject to regulatory approval, on or about August 28, 2020.
About Enlighta Inc.
Enlighta is a healthcare technology company positioned to provide Artificial Intelligence driven healthcare solutions and enable the transformation of intelligent medical services.
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
Forward Looking Statements:
Forward-looking statements relate to future events or future performance and reflect the expectations or beliefs regarding future events of management of Enlighta. This information and these statements, referred to herein as "forward‐looking statements", are not historical facts, are made as of the date of this news release and include without limitation, statements regarding discussions of future plans, estimates and forecasts and statements as to management's expectations and intentions with respect to the agreements with Enlighta. These statements generally can be identified by use of forward-looking terms such as "may", "will", "expect", "estimate", "anticipate", "intends", "believe" or "continue" or the negative thereof or similar variations. These forward‐looking statements involve numerous risks and uncertainties and actual results might differ materially from results anticipated in any forward-looking statements. Enlighta does not assume any obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those reflected in the forward looking-statements, other than as required by applicable securities laws.
For further information, please contact:
Alan Tam, CPA, CA
CFO, Enlighta Inc.
(604) 200-3803
SOURCE: Enlighta Inc.